Advertisement - Members don't see this ad
What are people's thoughts on the study out in Annals of Oncology of methylated cell-free DNA detection for multi-cancer detection? My personal experience is only with methylated septin9 blood testing for CRC. Does this multi-cancer early detection (MCED) test consist of a panel, including septin9 for CRC and additional ones for other solid/heme tumors? I wasn't able to see septin9 (SEPT9) mentioned at all in the full-text.
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set - Annals of Oncology
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set - Annals of Oncology
Last edited:
